Sexual Health After Endometriosis Surgery

Endometriosis Clinical Trial

— SSACE  

Official title:

Impact of Deep Endometriosis Surgery on Sexual Health

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03901885
• Other study ID #: 69HCL18_0656
• Status: Completed
• Phase: N/A
• Start date: April 9, 2019
• Est. completion date: February 9, 2020

Study information

• Verified date: June 2021
• Source: Hospices Civils de Lyon
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Endometriosis is a disease affecting between 5 and 15% of women and more than 40% of infertile women.

The main stakes of this disease are that it is benign but difficult to diagnose, often very painful, difficult to predict, potentially recurrent, while being resolvable at menopause. It affects women of childbearing age and can cause infertility and pain during intercourse. Also, by its characteristics, it can significantly deteriorate the quality of life.

The management of endometriosis, from diagnosis to treatment, is not consensual. There are medical or surgical treatments depending on the severity of the lesions, their location and the severity of the symptoms. Deep endometriosis, that is to say when there is digestive, urinary, utero sacral or peritoneal ligament more than 5mm deep, poses, in particular, a therapeutic problem because surgery is often the only option but it can be decadent.

Due to genital involvement, this disease has a real impact on the sexuality of patients. Surgery allows in a number of cases to reduce pain, including those occurring during intercourse. But the impact on sexuality in a more global way remains to be studied. The latter can be improved by the reduction of pain, but impacted by the surgery which is not insignificant on the representation of the woman of her own body.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 16
• Est. completion date: February 9, 2020
• Est. primary completion date: February 9, 2020
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Major women operated for deep endometriosis at the Lyon Sud Hospital Center (CHLS) of the Hospices Civils de Lyon (HCL).

Exclusion Criteria:

• Minor patient

• No indication for operation or indication of hysterectomy

• Isolated uterine adenomyosis

• Patient opposing her participation in the study

Related Conditions & MeSH terms

• Endometriosis

Intervention

Other:
• Female Sexual Function Index questionnaire
Assessment of FSFI (Female Sexual Function Index) questionnaires preoperatively and postoperatively (4 months).

Locations

Country	Name	City	State
France	Centre Hospitalier Lyon Sud	Pierre-Bénite

Sponsors (1)

Lead Sponsor	Collaborator
Hospices Civils de Lyon

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Consequences of the surgical management of a deep endometriosis on the quality of the sexual life of the patients.	Assessment of FSFI (Female Sexual Function Index) questionnaires preoperatively and postoperatively (4 months).	4 months